At #ACC26, DCRI’s @nishantshahmd.bsky.social offered up a practical recipe to take GLP-1 agonists from ‘pharm to table’ within any clinic, while still allowing physicians to add their own ‘spice’ to accommodate a patient’s unique needs. #cvMetabolic #ASCVD #CardioSky
🆕 #ACC26 Late-Breaking Trial 👇
Ez-PAVE: Lowering LDL-C to <55 mg/dL in patients with #ASCVD reduced the rate of major cardiovascular events by one-third.
Want the full results? Keep reading ➡️ https://bit.ly/414OLeG #cvPrev
Elevated Lp(a) doesn't just raise #CV risk, it carries a major economic price tag. Data shared by @nishantshahmd.bsky.social at #ACC26 shows the highest Lp(a) group incurs $506/person/year or $253M over 5 years, in indirect costs. The case for early testing is clear. #ASCVD #cvLipids #CardioSky
Join Ty Gluckman, MD, and colleagues for a case-based Master Class focused on closing gaps in ASCVD prevention — from Lp(a) testing to personalized lipid-lowering strategies.
Practical insights you can apply in clinic. Register: https://bit.ly/4aBDE1d
#Cardiology #ASCVD #MedicalEducation
Prevention is about clear communication and action, not just knowledge.
📖 Read more: https://ow.ly/uWZc50YxAXg
#Cardiology #PreventiveCardiology #HealthCommunication #ASCVD #CardioSky #MedSky
Consumo elevado de alimentos ultraprocesados se asocia con un riesgo elevado de eventos CV ateroscleróticos, siendo mayor el riesgo en los negros #UPF #ASCVD www.jacc.org/doi/10.1016/...
Higher consumption of ultraprocessed foods was significantly associated w/ an ↗️ risk for #ASCVD events, w/ a more pronounced association among Black Americans, based on findings from the MESA being presented at #ACC26.
Read more: https://bit.ly/4bBxAX2 #CardioSky #MedSky #JACCAdvances
The 2026 ACC/AHA Multisociety #Dyslipidemia Guideline-at-a-Glance offers a visual summary of key updates in CV risk assessment, lipid treatment goals, & #ASCVD risk reduction.
A quick reference for clinicians: https://bit.ly/4rGIMHY
#JACC #ClinicalGuidelines #cvLipids #CardioSky
Mala salud oral infantil, particularmente la caries dental persistente o empeorando, se asocia con un riesgo elevado de enfermedad CV aterosclerótica en la edad adulta #oralhealth #ASCVD www.internationaljournalofcardiology.com/article/S016...
ACC/AHA & 9 other leading medical associations released an updated clinical guideline for managing #dyslipidemia. About 1 in 4 US adults has high LDL-C, raising risk of heart attack & stroke.
Get the details in #JACC: https://bit.ly/4cLB0J0
#ClinicalGuidelines #cvLipids #ASCVD #CardioSky
Despite advances, #familial #hypercholesterolaemia is still inadequately diagnosed and undertreated, with many affected people remaining at high risk of early #cardiovascular disease www.thelancet.com/journals/lan...
#HeFH #HoFH #ASCVD
#MedSky #EndoSKY #CardioSky
New complimentary #CME!
Get a quick, practical update on LDL-C management in high-risk #ASCVD, including clinical data on new and emerging PCSK9 inhibitors (injectable & oral).
Earn 0.5 CME in 30 minutes.
clinical.med-iq.com/activity/ldl...
#CardioTwitter #MedEd #PCSK9
1/24 In this #CME #MedX, Dr. Blaha explores the evolving landscape of LDL-C management in high-risk patients with #ASCVD, with a focus on the role of PCSK9 inhibitors and a look at emerging novel PCSK9 inhibitor formulations.
Produced w/ @accintouch.bsky.social
Get credit: link.med-iq.com/Xc4w8B
With major advances in knowledge about the disease, #familial #hypercholesterolaemia has become an exemplar for the practice of precision and personalised medicine thelancet.com/journals/lan...
#HoFH #HeFH #ASCVD
#MedSky #EndoSky #CardioSky
Bar graphs show smallest worthwhile difference distributions for atherosclerotic cardiovascular disease risk in the US & Japan. Baseline risks are 2%, 10%, & 20%. X-axis: SWD in absolute risk reduction from baseline. Y-axis: percentage of US/Japanese participants.
Most statin-eligible adults in the US and Japan desire greater absolute risk reduction than current statin efficacy provides before initiating therapy for #ASCVD prevention.
ja.ma/46MbaRa
Editorial titled, "Statins for Primary Prevention—The Gap Between Guidelines and Patient Preferences" by Ilana B. Richman et al. Text discusses when to use statins for preventing atherosclerotic cardiovascular disease (ASCVD).
💬 Editorial: Statin guidelines and patient preferences for #ASCVD prevention often misalign, supporting the need for clearer risk communication and shared decision-making in clinical practice.
ja.ma/4rKRFAo
Bar graphs show smallest worthwhile difference distributions for atherosclerotic cardiovascular disease risk in the US & Japan. Baseline risks are 2%, 10%, & 20%. X-axis: SWD in absolute risk reduction from baseline. Y-axis: percentage of US/Japanese participants.
Most statin-eligible adults in the US and Japan desire greater absolute risk reduction than current statin efficacy provides before initiating therapy for #ASCVD prevention.
ja.ma/4kDy02Y
#MedNews - The oral PCSK9 inhibitor #enlicitide significantly reduces LDL-C levels in people with a history of, or risk for, #ASCVD events.
Full story 👉 buff.ly/jS4MBME
#CardioSky
New findings highlight clinician-level variation in lipid management for secondary ASCVD prevention, revealing opportunities to standardize care and improve outcomes.
🔗 https://ow.ly/7swS50Y8VHm
#LipidManagement #ASCVD #PreventiveCardiology #PracticeImprovement #CardioSky #MedSky
What predicts diffuse coronary artery calcium in adults ≥75?
New data from the ARIC study identify clinical predictors of diffuse CAC, offering insight into advanced atherosclerosis phenotypes in older adults.
🔗 https://ow.ly/EV4H50Y6mzu
#CardioEpi #CAC #ASCVD
Lluís Masana & Daiana Ibarretxe comment on:
Inclisiran for children: is it worth it? thelancet.com/journals/lan...
#heterozygous #familial #hypercholesterolaemia #HeFH #ASCVD
#MedSky #EndoSky #CardioSky
P. gingivalis in #Atherosclerotic plaques exacerbates plaque instability by disrupting the FOXO3-HDAC2 axis, driving #OxidativeStress-mediated macrophage #Necroptosis, thus establishing a causative link between periodontal health and #ASCVD.
#OpenAccess: doi.org/10.1038/s413...
The application of implementation science to expanding knowledge of #familial #hypercholesterolaemia has enabled the development and design of potentially more effective models of care thelancet.com/journals/lan...
#HoFH #HeFH #ASCVD
#MedSky #EndoSky #CardioSky
💊The newly published SURPASS-CVOT trial shows tirzepatide (Mounjaro) is as effective as dulaglutide in reducing major cardiovascular events in patients with type 2 diabetes and #ASCVD, expanding treatment options.
Read more in this TCTMD article➡️ https://ow.ly/izET50XTbeT
#CardioSky
Although heterozygous #familial #hypercholesterolaemia represents one of the most common monogenic conditions in the general population, homozygous familial hypercholesterolaemia is much rarer, occurring in between one in 160 000 & one in 450 000 individuals www.thelancet.com/journals/lan...
#ASCVD
Heart Attack Screening Tools Miss Nearly Half Of At-Risk People, Study Finds
Full Story: indiawest.com/heart-attack...
#HeartAttackRisk #HeartHealthStudy #HeartAttackScreening #CardiovascularRisk #SilentHeartDisease #ASCVD #PREVENTScore #MountSinaiStudy #HealthAlert
📣 #Colchicine for the prevention and management of Atherosclerotic #Cardiovascular Disease ⬇️
📌 In this review, van Zelm and colleagues review the evidence for the use of colchicine in #ASCVD
🆓 on TH 👉 www.thieme-connect.de/products/ejo...
#CardioEd #CAD #Cardiology #Cardiosky
Current efforts to manage #diabetes appear to have narrowed the gap between people with and without diabetes in terms of atherosclerotic CVD mortality, but not in terms of heart failure mortality www.thelancet.com/journals/lan...
#ASCVD #heartfailure
#MedSky #EndoSky #CardioSky
Despite advances, #familial #hypercholesterolaemia remains an underdiagnosed and untreated condition, with an urgent need for the design and implementation of effective models of care www.thelancet.com/journals/lan...
#ASCVD #HeFH #HoFH
#MedSky #EndoSky #CardioSky